Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Lifezone Metals | LZM | 27. sep 2024 | 7.03 | +2.03 |
Ligand Pharmaceuticals | LGND | 27. sep 2024 | 97.37 | -2.02 |
Light & Wonder | LNW | 27. sep 2024 | 92.38 | -0.77 |
Lightbridge | LTBR | 27. sep 2024 | 2.86 | +2.14 |
LightInTheBox Holding ADR | LITB | 27. sep 2024 | 2.99 | -0.99 |
LightPath Technologies A | LPTH | 27. sep 2024 | 1.39 | -0.71 |
Lightspeed Commerce | LSPD | 27. sep 2024 | 16.76 | +2.07 |
Lightwave Logic | LWLG | 27. sep 2024 | 2.95 | +3.15 |
Lilium N.V. A | LILM | 27. sep 2024 | 0.79 | +5.37 |
Limbach | LMB | 27. sep 2024 | 74.72 | +0.39 |
Limoneira | LMNR | 27. sep 2024 | 26.20 | -2.06 |
Lincoln Educational Services | LINC | 27. sep 2024 | 11.98 | +0.42 |
Lincoln Electric | LECO | 27. sep 2024 | 193.39 | -0.11 |
Lincoln National | LNC | 27. sep 2024 | 31.42 | +0.03 |
Lincoln National Pref | LNC-D | 27. sep 2024 | 28.40 | +0.07 |
Lindblad Expeditions | LIND | 27. sep 2024 | 9.30 | +0.76 |
Linde | LIN | 27. sep 2024 | 479.51 | -0.45 |
Lindsay | LNN | 27. sep 2024 | 124.14 | +1.09 |
Lineage | LINE | 27. sep 2024 | 78.29 | 0.00 |
Lineage Cell Therapeutics | LCTX | 27. sep 2024 | 0.92 | +6.75 |
Linkage Global | LGCB | 27. sep 2024 | 0.40 | -1.21 |
Linkbancorp | LNKB | 27. sep 2024 | 6.43 | +1.90 |
Lion ADR | LGHL | 27. sep 2024 | 0.24 | -1.94 |
Lion Electric | LEV | 27. sep 2024 | 0.68 | +1.23 |
Lionheart Units | CUBWU | 27. sep 2024 | 10.17 | +1.29 |
Lions Gate Entertainment A | LGF-A | 27. sep 2024 | 8.02 | +0.63 |
Lions Gate Entertainment B | LGF-B | 27. sep 2024 | 7.09 | +0.85 |
Lipella Pharmaceuticals | LIPO | 27. sep 2024 | 0.49 | -3.39 |
Lipocine | LPCN | 27. sep 2024 | 4.44 | -4.31 |
LiqTech International | LIQT | 27. sep 2024 | 3.04 | -1.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.